BioCentury | Apr 29, 2020
Product Development

April 28 Quick Takes: Syndax gains on leukemia data; plus Supernus, Neurocrine, Avadel, Insilico-Astellas, Innovent-Lilly, Chimerix

...Supernus acquiring neurology portfolio Supernus Pharmaceuticals Inc. (NASDAQ:SUPN) plans to acquire a neurology portfolio from US WorldMeds LLC...
BioCentury | Jan 5, 2019
Finance

Ready to launch

The proposed $74 billion takeout of Celgene Corp. by Bristol-Myers Squibb Co. will not shift buysider attention away from upcoming and maturing drug launches heading into 2019, with plenty to track following a record year...
BioCentury | May 18, 2018
Clinical News

FDA approves US WorldMeds' Lucemyra for opioid withdrawal

...FDA approved Lucemyra lofexidine from US WorldMeds LLC (Louisville, Ky.) for the mitigation of withdrawal symptoms to facilitate...
...agency, Lucemyra is the first non-opioid drug approved by FDA to manage opioid withdrawal symptoms. US WorldMeds...
...Bad Vilbel, Germany US WorldMeds LLC, Louisville, Ky. Product: Lucemyra lofexidine Business: Neurology Chris Lieu BritLofex, Lucemyra, lofexidine Stada Arzneimittel AG US WorldMeds LLC Adrenergic...
BioCentury | May 16, 2018
Company News

FDA approves US WorldMeds' Lucemyra for opioid withdrawal

...FDA approved Lucemyra lofexidine from US WorldMeds LLC (Louisville, Ky.) for the mitigation of withdrawal symptoms to facilitate...
...agency, Lucemyra is the first non-opioid drug approved by FDA to manage opioid withdrawal symptoms. US WorldMeds...
...Psychopharmacologic Drugs Advisory Committee voted 11-1 recommending approval of Lucemyra's NDA, which had Priority Review. US WorldMeds...
BioCentury | Apr 6, 2018
Finance

Smid-cap smorgasbord

...SPR994) Multi-drug resistant Gram-negative infections Top-line Ph I data Mid-2018 Stada Arzneimittel AG (Xetra:SAZ) / US WorldMeds LLC...
BioCentury | Mar 30, 2018
Clinical News

FDA panel backs US WorldMeds' opioid withdrawal candidate

...US WorldMeds said lofexidine would be the first FDA-approved non-opioid, non-addictive drug to manage opioid withdrawal. US WorldMeds...
...Xetra:SAZ), Bad Vilbel, Germany US WorldMeds LLC, Louisville, Ky. Product: Lofexidine Business: Neurology Elizabeth S. Eaton BritLofex, lofexidine Stada Arzneimittel AG US WorldMeds LLC Adrenergic...
BioCentury | Mar 9, 2018
Clinical News

FDA panel to review US WorldMeds' opioid withdrawal candidate

...its Psychopharmacologic Drugs Advisory Committee will meet on March 27 to discuss an NDA from US WorldMeds LLC...
...US WorldMeds said lofexidine would be the first FDA-approved non-opioid, non-addictive drug to manage opioid withdrawal. US WorldMeds...
...Xetra:SAZ), Bad Vilbel, Germany US WorldMeds LLC, Louisville, Ky. Product: Lofexidine Business: Neurology Elizabeth S. Eaton BritLofex, lofexidine Stada Arzneimittel AG US WorldMeds LLC Adrenergic...
BioCentury | Jan 6, 2018
Finance

Burgeoning bellwethers

...Burosumab X-linked hypophosphatemia (XLH) in adult and pediatric patients EMA approval; PDUFA date 1Q18; 4/17/18 US WorldMeds LLC...
...2015) Neurocrine Biosciences Inc. (NASDAQ:NBIX) Ingrezza valbenazine Tardive dyskinesia U.S. Newron Pharmaceuticals S.p.A. (SIX:NWRN) / US WorldMeds LLC...
BioCentury | Dec 1, 2017
Company News

FDA reviewing US WorldMeds’ opioid withdrawal candidate

...FDA accepted and granted Priority Review to an NDA for lofexidine from US WorldMeds LLC (Louisville, Ky.) to...
...company said lofexidine would be the first FDA-approved non-opioid, non-addictive drug to manage opioid withdrawal. US WorldMeds...
...Arzneimittel AG (Xetra:SAZ), Bad Vilbel, Germany US WorldMeds LLC, Louisville, Ky. Product: Lofexidine Business: Neurology Alicia Parker lofexidine Stada Arzneimittel AG US WorldMeds LLC...
BioCentury | Nov 21, 2017
Company News

FDA reviewing US WorldMeds’ opioid withdrawal candidate

...FDA accepted and granted Priority Review to an NDA for lofexidine from US WorldMeds LLC (Louisville, Ky.) to...
...company said lofexidine would be the first FDA-approved non-opioid, non-addictive drug to manage opioid withdrawal. US WorldMeds...
...Stada Arzneimittel AG (Xetra:SAZ) acquired in 2007, markets the drug in the U.K. as BritLofex. Alicia Parker lofexidine US WorldMeds LLC Adrenergic...
Items per page:
1 - 10 of 27
BioCentury | Apr 29, 2020
Product Development

April 28 Quick Takes: Syndax gains on leukemia data; plus Supernus, Neurocrine, Avadel, Insilico-Astellas, Innovent-Lilly, Chimerix

...Supernus acquiring neurology portfolio Supernus Pharmaceuticals Inc. (NASDAQ:SUPN) plans to acquire a neurology portfolio from US WorldMeds LLC...
BioCentury | Jan 5, 2019
Finance

Ready to launch

The proposed $74 billion takeout of Celgene Corp. by Bristol-Myers Squibb Co. will not shift buysider attention away from upcoming and maturing drug launches heading into 2019, with plenty to track following a record year...
BioCentury | May 18, 2018
Clinical News

FDA approves US WorldMeds' Lucemyra for opioid withdrawal

...FDA approved Lucemyra lofexidine from US WorldMeds LLC (Louisville, Ky.) for the mitigation of withdrawal symptoms to facilitate...
...agency, Lucemyra is the first non-opioid drug approved by FDA to manage opioid withdrawal symptoms. US WorldMeds...
...Bad Vilbel, Germany US WorldMeds LLC, Louisville, Ky. Product: Lucemyra lofexidine Business: Neurology Chris Lieu BritLofex, Lucemyra, lofexidine Stada Arzneimittel AG US WorldMeds LLC Adrenergic...
BioCentury | May 16, 2018
Company News

FDA approves US WorldMeds' Lucemyra for opioid withdrawal

...FDA approved Lucemyra lofexidine from US WorldMeds LLC (Louisville, Ky.) for the mitigation of withdrawal symptoms to facilitate...
...agency, Lucemyra is the first non-opioid drug approved by FDA to manage opioid withdrawal symptoms. US WorldMeds...
...Psychopharmacologic Drugs Advisory Committee voted 11-1 recommending approval of Lucemyra's NDA, which had Priority Review. US WorldMeds...
BioCentury | Apr 6, 2018
Finance

Smid-cap smorgasbord

...SPR994) Multi-drug resistant Gram-negative infections Top-line Ph I data Mid-2018 Stada Arzneimittel AG (Xetra:SAZ) / US WorldMeds LLC...
BioCentury | Mar 30, 2018
Clinical News

FDA panel backs US WorldMeds' opioid withdrawal candidate

...US WorldMeds said lofexidine would be the first FDA-approved non-opioid, non-addictive drug to manage opioid withdrawal. US WorldMeds...
...Xetra:SAZ), Bad Vilbel, Germany US WorldMeds LLC, Louisville, Ky. Product: Lofexidine Business: Neurology Elizabeth S. Eaton BritLofex, lofexidine Stada Arzneimittel AG US WorldMeds LLC Adrenergic...
BioCentury | Mar 9, 2018
Clinical News

FDA panel to review US WorldMeds' opioid withdrawal candidate

...its Psychopharmacologic Drugs Advisory Committee will meet on March 27 to discuss an NDA from US WorldMeds LLC...
...US WorldMeds said lofexidine would be the first FDA-approved non-opioid, non-addictive drug to manage opioid withdrawal. US WorldMeds...
...Xetra:SAZ), Bad Vilbel, Germany US WorldMeds LLC, Louisville, Ky. Product: Lofexidine Business: Neurology Elizabeth S. Eaton BritLofex, lofexidine Stada Arzneimittel AG US WorldMeds LLC Adrenergic...
BioCentury | Jan 6, 2018
Finance

Burgeoning bellwethers

...Burosumab X-linked hypophosphatemia (XLH) in adult and pediatric patients EMA approval; PDUFA date 1Q18; 4/17/18 US WorldMeds LLC...
...2015) Neurocrine Biosciences Inc. (NASDAQ:NBIX) Ingrezza valbenazine Tardive dyskinesia U.S. Newron Pharmaceuticals S.p.A. (SIX:NWRN) / US WorldMeds LLC...
BioCentury | Dec 1, 2017
Company News

FDA reviewing US WorldMeds’ opioid withdrawal candidate

...FDA accepted and granted Priority Review to an NDA for lofexidine from US WorldMeds LLC (Louisville, Ky.) to...
...company said lofexidine would be the first FDA-approved non-opioid, non-addictive drug to manage opioid withdrawal. US WorldMeds...
...Arzneimittel AG (Xetra:SAZ), Bad Vilbel, Germany US WorldMeds LLC, Louisville, Ky. Product: Lofexidine Business: Neurology Alicia Parker lofexidine Stada Arzneimittel AG US WorldMeds LLC...
BioCentury | Nov 21, 2017
Company News

FDA reviewing US WorldMeds’ opioid withdrawal candidate

...FDA accepted and granted Priority Review to an NDA for lofexidine from US WorldMeds LLC (Louisville, Ky.) to...
...company said lofexidine would be the first FDA-approved non-opioid, non-addictive drug to manage opioid withdrawal. US WorldMeds...
...Stada Arzneimittel AG (Xetra:SAZ) acquired in 2007, markets the drug in the U.K. as BritLofex. Alicia Parker lofexidine US WorldMeds LLC Adrenergic...
Items per page:
1 - 10 of 27